0001161697-22-000319.txt : 20220623 0001161697-22-000319.hdr.sgml : 20220623 20220623170237 ACCESSION NUMBER: 0001161697-22-000319 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220621 FILED AS OF DATE: 20220623 DATE AS OF CHANGE: 20220623 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: INGENITO GARY CENTRAL INDEX KEY: 0001279473 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33057 FILM NUMBER: 221036193 MAIL ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 1500 CITY: CORAL GABLES STATE: FL ZIP: 33134 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001369568 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 BUSINESS PHONE: (305) 529-2522 MAIL ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 FORMER COMPANY: FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC. DATE OF NAME CHANGE: 20110215 FORMER COMPANY: FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc. DATE OF NAME CHANGE: 20060719 4 1 form4.xml FORM 4 FOR 06-21-2022 X0306 4 2022-06-21 0 0001369568 CATALYST PHARMACEUTICALS, INC. CPRX 0001279473 INGENITO GARY 355 ALHAMBRA CIRCLE, SUITE 801 CORAL GABLES FL 33134 0 1 0 0 Chief Medical & Reg. Officer Common stock, par value $0.001 per share 2022-06-21 4 M 0 143848 4.13 A 165901 D Common stock, par value $0.001 per share 2022-06-21 4 S 0 143848 6.595 D 22053 D Common stock, par value $0.001 per share 2022-06-22 4 M 0 6152 4.13 A 28205 D Common stock, par value $0.001 per share 2022-06-22 4 S 0 6152 6.607 D 22053 D Options to purchase common stock 4.13 2022-06-21 4 M 0 143848 0 D 2022-06-30 Common Stock 143848 1077819 D Options to purchase common stock 4.13 2022-06-22 4 M 0 6152 0 D 2022-06-30 Common Stock 6152 1071667 D Dr. Ingenito sold the shares on the open market for personal reasons and not as a result of any disagreement with the Registrant. Dr. Ingenito remains an officer of the Company. Shares were sold in various lots from $6.55 to $6.68 per share. The listed sale price represents a weighted average price for the shares sold. Shares were sold in various lots from $6.55 to $6.71 per share. The listed sale price represents a weighted average price for the shares sold. Options vested in three annual tranches beginning on June 30, 2016. /s/ Gary Ingenito 2022-06-23